| 697888 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer |
2021-06-01 |
10.1136/jitc-2020-002131 |
Zhai Tianhang, Wang Chao, Xu Yifeng, Huang Weifeng, Yuan Zhijun, Wang Tao, Dai Shuang, Peng Shaogang, Pang Tuling, Jiang Wenchao, Huang Yuhua, Zou Yuefeng, Xu Yingda, Sun Joanne, Gong Xinjiang, Zhang Jinping, Tsun Andy, Li Bin, Miao Xiaoniu |
| 697887 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem |
2021-06-01 |
10.1136/jitc-2021-002916 |
Poels Kikkie, Neppelenbroek Suzanne I.M., Kersten Marie José, Antoni M. Louisa, Lutgens Esther, Seijkens Tom T.P. |
| 697886 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial |
2021-06-01 |
10.1136/jitc-2020-002296 |
Duerinck Johnny, Schwarze Julia Katharina, Awada Gil, Tijtgat Jens, Vaeyens Freya, Bertels Cleo, Geens Wietse, Klein Samuel, Seynaeve Laura, Cras Louise, D’Haene Nicky, Michotte Alex, Caljon Ben, Salmon Isabelle, Bruneau Michaël, Kockx Mark, Van Dooren Sonia, Vanbinst Anne-Marie, Everaert Hendrik, Forsyth Ramses, Neyns Bart |
| 697885 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies |
2021-06-01 |
10.1136/jitc-2021-002630 |
Goldman Jason D, Robinson Philip C, Uldrick Thomas S, Ljungman Per |
| 697884 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Phase II clinical trial using anti-CD3 × anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) consolidation therapy for HER2 negative (0–2+) metastatic breast cancer |
2021-06-01 |
10.1136/jitc-2020-002194 |
Lum Lawrence G., Al-Kadhimi Zaid, Deol Abhinav, Kondadasula Vidya, Schalk Dana, Tomashewski Elyse, Steele Patricia, Fields Kristie, Giroux Melissa, Liu Qin, Flaherty Lawrence, Simon Michael, Thakur Archana |
| 697883 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients |
2021-06-01 |
10.1136/jitc-2021-002932 |
Romano Emanuela, Pascolo Steve, Ott Patrick |
| 697882 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Mesoporous silica nanoparticles inflame tumors to overcome anti-PD-1 resistance through TLR4-NFκB axis |
2021-06-01 |
10.1136/jitc-2021-002508 |
Sun Mayu, Gu Pengfei, Yang Yang, Yu Luodan, Jiang Zheshun, Li Jingquan, Le Yingying, Chen Yu, Ba Qian, Wang Hui |
| 697881 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors |
2021-06-01 |
10.1136/jitc-2021-002349 |
Ahmed Murtaza, von Itzstein Mitchell S, Sheffield Thomas, Khan Shaheen, Fattah Farjana, Park Jason Y, Popat Vinita, Saltarski Jessica M, Gloria-McCutchen Yvonne, Hsiehchen David, Ostmeyer Jared, Khan Saad A, Sultana Nazima, Xie Yang, Li Quan-Zhen, Wakeland Edward K, Gerber David E |
| 697880 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells |
2021-06-01 |
10.1136/jitc-2020-002240 |
Fucà Giovanni, Ambrosini Margherita, Agnelli Luca, Brich Silvia, Sgambelluri Francesco, Mortarini Roberta, Pupa Serenella M, Magni Michele, Devizzi Liliana, Matteucci Paola, Cabras Antonello, Zappasodi Roberta, De Santis Francesca, Anichini Andrea, De Braud Filippo, Gianni Alessandro M, Di Nicola Massimo |
| 697879 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immune landscape and subtypes in primary resectable oral squamous cell carcinoma: prognostic significance and predictive of therapeutic response |
2021-06-01 |
10.1136/jitc-2021-002434 |
Diao Pengfei, Jiang Yue, Li Yuanyuan, Wu Xiang, Li Jin, Zhou Chen, Jiang Lei, Zhang Wei, Yan Enshi, Zhang Ping, Ding Xu, Wu Heming, Yuan Hua, Ye Jinhai, Song Xiaomeng, Wan Linzhong, Wu Yunong, Jiang Hongbing, Wang Yanling, Cheng Jie |
